A Multicenter Randomized Trial Evaluating Posaconazole versus Fluconazole for the Treatment of Oropharyngeal Candidiasis in Subjects with HIV/AIDS
Clinical Infectious Diseases2006Vol. 42(8), pp. 1179–1186
Citations Over TimeTop 1% of 2006 papers
José A. Vázquez, Daniel J. Skiest, Leonardo Nieto, R Northland, I. Sanne, Jagadish Gogate, Wayne Greaves, Randi Isaacs
Abstract
Results demonstrate that posaconazole was as effective as fluconazole in producing a successful clinical outcome. However, posaconazole was more effective in sustaining clinical success after treatment was stopped.
Related Papers
- → Synergistic Interactions between Pseudomonas aeruginosa and Candida albicans, Candida glabrata, Candida krusei, Candida parapsilosis as well as Candida tropicalis in the Formation of Polymicrobial Biofilms(2024)8 cited
- → Outcomes with micafungin in patients with candidaemia or invasive candidiasis due to Candida glabrata and Candida krusei(2010)22 cited
- → Efficacy of Triazoles in a Murine Disseminated Infection by Candida krusei(2009)9 cited
- Clinical distribution and drug resistance of candida infection(2008)
- Study of Aqueous and Alcoholic Extract of the Melissa Officinalis Effect on Candida albicans, Candida glabrata and Candida krusei(2018)